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Background/aim: Although ulnar neuropathy at the elbow (UNE) is the second most common entrapment mononeuropathy, there are
few reports on its neurophysiological classification. In this study, we tried to find out the role of needle electromyography (EMG) in the
neurophysiological classification of UNE.
Materials and methods: UNE patients who met the clinical and neurophysiological diagnostic criteria and healthy individuals
were included in this study. Reference values of nerve conduction studies were obtained from healthy individuals. Needle EMG was
performed to all UNE patients. According to the neurophysiological classification proposed by Padua, UNE patients were classified as
mild, moderate, and severe.
Results: Thirty-one controls and thirty-five UNE patients were included in the study. There was mild UNE in 23 patients, moderate
UNE in 8, and severe UNE in 4. Abnormal needle EMG findings were present in all patients with moderate and severe UNE and in 12
patients with mild UNE.
Conclusion: Abnormal needle EMG findings are seen in most of the UNE patients. Therefore, it is not practical to use needle EMG
findings in the neurophysiological classification. Needle EMG abnormalities may also be present in patients with mild UNE due to
axonal degeneration or motor conduction block.
Key words: Needle electromyography, neurophysiological classification, ulnar neuropathy at the elbow

1. Introduction
Ulnar neuropathy at the elbow (UNE) is a common
mononeuropathy, and nerve conduction study is
important for its diagnosis. The American Association
of Neuromuscular and Electrodiagnostic Medicine
recommends using the following criteria in the diagnosis
of UNE: slowing of motor nerve conduction velocity
(NCV) at the elbow segment, increased velocity difference
between the motor NCV of the forearm and elbow
segments (FEVD), a 20% reduction in the compound
muscle action potential (CMAP) amplitude or a CMAP
morphology change above the elbow compared to the
CMAP obtained by stimulating the ulnar nerve below
the elbow [1,2]. Short-segment motor nerve conduction
studies across the elbow are recommended and are
considered as gold standard for diagnosis of UNE and
localization of the lesion [3–6].
Although UNE is the second most common entrapment
mononeuropathy following carpal tunnel syndrome

and there are many classifications and questionnaires
according to clinical features or examination findings
[7–9], there are few publications on its neurophysiological
classification [10,11]. The UNE classification suggested by
Padua et al. seems to be a good one, but it does not include
needle electromyography (EMG) findings [10]. In another
recently proposed classification, needle EMG findings were
included in addition to nerve conduction studies, and this
article describes the classification based on two cases [11].
We planned our study based on the classification proposed
by Padua et al. and aimed to determine the role of needle
EMG in the neurophysiological classification of UNE.
2. Materials and methods
2.1. Study design and subjects
Healthy individuals and UNE patients older than 18
years of age who applied to the Neurology Department
of Adana City Training & Research Hospital (ACTRH)
between November 2018 and June 2019 were included in
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the study. Written informed consent was obtained from
all participants. The study was approved by the Ethics
Committee of ACTRH (number: 25/335). Median, ulnar,
tibial, peroneal, superficial peroneal, and sural nerve
conduction studies were performed on all subjects by
a clinical neurophysiologist and a neurologist. Nerve
conduction studies were performed bilaterally on the
upper extremities of all UNE patients. First, we formed
a control group consisting of healthy individuals for
the upper and lower limits of normal values for nerve
conduction studies. If the participant had any of the
following, they were not included in the control group:
paresthesia on the extremities, muscle weakness, elbow
pain, history of elbow fracture or elbow surgery, a
neurodegenerative disease, mononeuropathies, a disorder
that could cause polyneuropathy such as diabetes mellitus,
a neuromuscular disorder, or abnormality in neurological
examination such as decreased tendon reflexes. In addition,
individuals with a family history of neurodegenerative
disease or hereditary polyneuropathy were excluded from
the study. The UNE group consisted of patients who met
both clinical and neurophysiological criteria [12,13]. The
clinical criteria were two or more of the following: 1)
subjective paresthesia or numbness of the fourth and fifth
fingers, 2) abnormalities in the sensory area of the
 ulnar
nerve detected on neurological examination, 3) weakness
of the ulnar nerve innervated muscles detected on
neurological examination. To meet the neurophysiological
criteria, the latency difference or CMAP amplitude drop
obtained from the short-segment motor nerve conduction
study had to be higher than the upper limits of normal
values, or ulnar motor NCV at the elbow segment had to
be slower than the lower limits of normal value. The UNE
patients had the same exclusion criteria as the controls,
except for clinical and neurological examination findings
compatible with ulnar neuropathy. Individuals suggestive
of Martin-Gruber anastomosis in nerve conduction
studies were excluded. In case of abnormalities in ulnar
nerve innervated muscles, other muscles such as abductor
pollicis brevis were also examined for differential diagnosis.
Clinical and needle EMG findings compatible with cervical
radiculopathy or brachial plexopathy were excluded from
the study. The Turkish version of disabilities of the arm,
shoulder, and hand (DASH) questionnaire was used to
measure upper extremity disability and symptoms [14].
The DASH questionnaire consisting of 30 questions was
administered to all patients, and the disability/symptom
score was calculated.
2.2. Electrodiagnostic tests
All studies were performed with Cadwell Sierra Summit
EMG unit (Cadwell laboratories, Kennewick, Washington,
USA). Surface electrodes were used for stimulation and
recording. Nerve conduction studies were performed
when the extremities were above 32 °C. Cold extremities

were heated. Band-pass filters for sensory and motor
nerve conduction studies were set at 20 Hz to 2 kHz and
20 Hz to 10 kHz, respectively. Nerves were stimulated
supramaximally. Sensitivity was 2 mV/division, and
sweep speed was 5 ms/division in motor conduction
studies. In sensory nerve conduction studies, sensitivity
and sweep speed were set to 10 µV and 1 ms/division,
respectively. CMAP and sensory nerve action potential
(SNAP) amplitudes were measured from peak to peak.
Sensory NCV was calculated using peak latency, except
that superficial peroneal nerve velocity was calculated
using onset latency. Median sensory nerve conduction
studies were performed orthodromically by stimulating
the 1st, 2nd, 3rd fingers, and the palm. Superficial peroneal
and sural nerve conduction studies were performed
antidromically. Motor nerve stimulation was performed 5,
8, and 10 cm proximal to the active recording electrode at
the wrist and ankle to obtain the median, peroneal, and
tibial nerve CMAP, respectively. Minimal F-wave latencies
were determined by evaluating at least 10 responses. The
ulnar motor nerve conduction study was performed by
recording from abductor digiti minimi (ADM) and first
dorsal interosseous (FDI) muscles. Buschbacher’s method
was used for ulnar motor nerve conduction [15,16]. Nerve
conduction studies were performed with the arm at 45°
abduction and the elbow at 90° flexion. Distal stimulation
point was 5 cm proximal to active electrode on ADM
muscle to obtain ulnar CMAP and 12 cm (pathway of
ulnar nerve was measured) proximal to active electrode
on FDI muscle. Proximal stimulation points were 4 cm
distal and 6 cm proximal to the medial epicondyle. Shortsegment motor nerve conduction was performed based on
Kanakamedala’s method [4]. A line was drawn between
the medial epicondyle and olecranon (E), and points were
placed at both distal (D2, D4) and proximal (P2, P4, P6)
at 2 cm intervals from E. Stimulation was performed on
these six points. Ulnar sensory nerve conduction study was
performed orthodromically by stimulation of the 5th finger.
Forearm and upper arm mixed nerve conduction studies
were also performed. Based on the classification used by
Padua et al., the neurophysiological classification of UNE
was made as follows [10]: 1) Negative UNE: normal ulnar
nerve conduction study, 2) Mild UNE: slowing of ulnar
motor NCV across the elbow, 3) Moderate UNE: slowing
of ulnar motor NCV across the elbow and reduction of the
SNAP amplitude, 4) Severe UNE: slowing of ulnar motor
NCV across the elbow and absence of SNAP (5th fingerwrist segment), 5) Extreme UNE: absence of ulnar CMAP
and SNAP (5th finger-wrist segment). Extreme UNE
patients were excluded because localization could not be
determined. In addition, negative UNE patients were not
included in the UNE group. Needle EMG was performed
visually using concentric EMG needle electrode (length
= 50mm, diameter = 0.46 mm, Bionen medical devices,
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Florence, Italy). Concentric needle EMG of ADM, FDI,
flexor digitorum profundus of fourth-fifth fingers (FDP)
and flexor carpi ulnaris (FCU) muscles were performed
in all UNE patients. High-pass and low-pass filters were
set at 10 Hz and 10 kHz, respectively. Sensitivity was
50µV/division for the analyses of spontaneous activity
and 200–1000 µV/division for motor unit action potential
(MUP) evaluation. Sweep speed was 10 ms/division for the
analyses of spontaneous activity and MUPs. Positive sharp
waves (PSW) and fibrillations were carefully evaluated.
At least 10–20 MUPs (according to patients’ tolerability)
were recorded during mild muscle contraction. MUP
was considered chronic neurogenic if: MUP peak to peak
amplitude was ≥4 mV and/or MUP duration was ≥15 ms.
2.3. Statistical analysis
The Shapiro–Wilk test was used to determine the
distribution of the data. Group comparisons were made
using the Mann–Whitney U test for independent samples.
Pearson’s chi-squared test was used to analyze categorical
variables. Spearman’s test was used for correlation analysis.
Mean ± standard deviation (SD) and median of numeric
data were calculated for descriptive statistics. Upper and
lower limits were calculated as mean ± 2 SD for normally
distributed variables and as 2.25th or 97.75th percentile
values for data that were not normally distributed [17]. A
P-value of less than 0.05 was considered significant. SPSS
(IBM Corp; Armonk, NY, USA) 22.0 was used to perform
the statistical analysis.
3. Results
The control and UNE groups consisted of 31 and 35
individuals, respectively. Thirteen of the controls (42%)
and twelve of the UNE patients were female (34%). The
mean ages of the control and UNE groups were 37.8
± 11.7 (range: 18–64) and 41.6 ± 15.2 (range: 18–77),
respectively. The mean height, weight, and body mass
index (BMI) of the controls were 170.3 ± 8.1 cm, 74.8
± 11.6 kg, and 25.8 ± 3.8 kg/m2, respectively, and these
values w
 ere 172.1 ± 8.9 cm, 76.3 ± 13.1 kg, 25.7 ± 3.8 kg/m2
for the UNE group, respectively. No statistically significant
difference was found between the groups in terms of age,
sex, height, weight, and BMI. Nerve conduction study was
performed on the right upper and lower extremities in 14
of the controls (45%). Twelve of UNE patients (34%) had
ulnar neuropathy on the right side. The mean duration
of symptoms was 7.6 ± 12.1 (range: 1–60) months. All
UNE patients had paresthesia at the 4th and 5th fingers.
Twenty-one (60%) patients had paresthesia on the palm.
Fourteen patients (40%) had elbow or forearm pain. In
neurological examination, sensory abnormalities in the
4th/5th fingers and ulnar side of palm were found in 33
(94%) and 25 patients (71%), respectively. Neurological
examination revealed weakness in ADM and FDI in 13
(37%) and 14 (40%) patients, respectively. Atrophy was
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found in ADM muscle in 4 (11%) patients and in FDI
muscle in 6 (17%) patients. Elbow flexion compression
test and Tinel’s test were positive in 21 (60%) and 13 (37%)
patients, respectively.
The upper or lower limits of reference values for nerve
conduction studies obtained from the controls were as
follows; ulnar SNAP 5th finger–wrist segment amplitude
7.1 µV, NCV 38.8 m/s; ulnar mixed nerve forearm, upper
arm segments amplitude 7.0 µV, 4.4 µV, NCV 47.9 m/s,
49.6 m/s; ulnar nerve distal CMAP latency 2.9 ms (ADM),
4.9 ms (FDI), amplitude 8.0 mV (ADM), 6.4 mV (FDI);
ulnar motor NCV wrist–below elbow segment 52 m/s
(ADM), 50.9 m/s (FDI); ulnar motor NCV below elbow–
above elbow segment 43 m/s (ADM), 45.7 m/s (FDI). The
upper reference limits of the latency difference obtained
from ADM/FDI muscles across D4-D2, D2-E, E-P2, P2P4, P4-P6 segments were 0.6/0.5, 0.6/0.7, 0.7/0.8, 0.5/0.7,
0.6/0.5 ms, respectively. In the short segment ulnar motor
nerve conduction study recorded from ADM and FDI
muscles, the upper limits of normal values obtained from
controls for amplitude reduction at D2, E, P2, P4, P6 points
were 10%, 10%, 10%, 13%, 14% (ADM) and 6%, 22%, 22%,
26%, 27% (FDI), respectively. The upper reference limit of
amplitude drop in percentage across elbow segment was
14.9% for ADM muscle and it was 22.7% for FDI muscle.
The upper reference limits of FEVD recorded from ADM
and FDI muscles were 15.0 and 14.3 m/s, respectively.
Considering the reference values obtained from healthy
individuals, 2 patients had carpal tunnel syndrome in
addition to ulnar neuropathy, and 1 patient had sural
and median nerve SNAP abnormalities in addition to
ulnar neuropathy, and these three patients were excluded
from the UNE group. Although nine patients had clinical
findings, these patients were excluded due to normal nerve
conduction studies. Nerve conduction study abnormalities
in UNE patients are shown in Table 1. The PSW and/or
fibrillation potentials in ADM, FDI, FDP, FCU muscles
were observed in 10, 15, 2, and 3 patients, respectively.
Neurogenic changes in ADM, FDI, FDP, FCU muscles
were observed in 14, 12, 7, and 10 patients, respectively.
According to the classification of Padua et al., 23 patients
had mild UNE, 8 patients had moderate UNE, and 4
patients had severe UNE. All patients in the moderate and
severe UNE groups had needle EMG abnormalities in at
least one of the ADM, FDI, FDP, and FCU muscles. Needle
EMG of these four muscles was normal in 11 patients in
the mild UNE group. Needle EMG findings in each UNE
group are shown in Table 2. Table 3 shows the comparison
of nerve conduction studies in mild UNE patients with
normal and abnormal needle EMG findings. Latency
difference was prolonged in the E-P2 (29 patients), D2-E
(5 patients), and P2-P4 (1 patient) segments in UNE.
Four of five patients with prolonged latency in the D2-E
segment were in the severe UNE group, and one was in
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Table 1. Abnormal nerve conduction study in UNE patients.
Number of extremities with
abnormal values (%)
Sensory nerve conduction
5th digit-wrist segment SNAP amplitude <7.1 µV or velocity <38.8 m/s

12 (34)

Mixed nerve conduction
Forearm segment amplitude < 7.0µV or velocity < 47.9m/s

14 (40)

Upper arm segment amplitude < 4.4µV or velocity < 49.6m/s

16 (46)

Motor nerve conduction CMAP amplitude –ADM < 8.0 mV/ FDI < 6.4mV

6 (17) / 5 (14)

Motor nerve conduction (Elbow segment)
Velocity (ADM) < 43 m/s / (FDI) < 45.7 m/s

15 (43) / 20(57)

FEVD (ADM) > 15 m/s / (FDI) > 14.3 m/s

17(49) / 20(57)

Amplitude drop (ADM) > 14.9% / (FDI) > 22.7%

13(37) / 12(34.0)

Short-segment ulnar motor nerve conduction
Abnormal latency difference (ADM) / (FDI)

31 (89) / 30 (86)

Abnormal amplitude drop (ADM) / (FDI)

14 (40) / 12(34)

SNAP: sensory nerve action potential, FEVD: the velocity difference between the motor NCV of the forearm and
elbow segments, ADM: abductor digiti minimi, FDI: first dorsal interosseous.
Table 2. Needle EMG findings in each UNE group.
Needle EMG abnormality
(fibrillation potentials/PSW or
neuropathic changes)

Mild UNE
patients n = 23

Moderate UNE
patients n = 8

Severe UNE
patients n = 4

All UNE
patients (%) n = 35

ADM

10

5

4

19 (54%)

FDI

10

7

4

21 (60%)

FDP

4

2

2

8 (23%)

FCU

5

2

4

11(31%)

ADM or FDI or FDP or FCU (%)

12 (52%)

8 (100%)

4 (100%)

24 (69%)

EMG: electromyography, ADM: abductor digiti minimi, FDI: first dorsal interosseous, FDP: flexor digitorum profundus
of fourth-fifth fingers, FCU: flexor carpi ulnaris, PSW: positive sharp waves.

the mild UNE group. Needle EMG findings of these five
patients were abnormal in at least one muscle. The mean
± SD (median) values of DASH scores were 23.3 ± 17.1
(21), 44 ± 18 (50), and 43 ± 21 (40) in the mild, moderate,
and severe UNE groups, respectively. There was a positive
correlation between DASH scores and neurophysiological
classification of UNE (P = 0.003, r = 0.506).
4. Discussion
We determined the upper or lower limits of median, ulnar,
tibial, peroneal, and sural nerves from healthy individuals
before including UNE patients in the study. Thus, two
UNE patients with carpal tunnel syndrome and one with
abnormalities in sural and median nerve conduction

studies were not included in the UNE group. Needle EMG
findings in these three patients could be confusing. Nine
patients (21%) had clinical findings suggestive of UNE, but
unfortunately, these patients had normal nerve conduction
studies. This finding was similar to other studies [10,12].
To increase sensitivity in the diagnosis of UNE, it is
recommended by some to perform ultrasonography or
ulnar motor nerve conduction study recorded from the
FDI muscle [6,12,18]. We also performed an ulnar motor
nerve conduction study by recording from both ADM
and FDI muscles. In the short-segment ulnar motor nerve
conduction study recorded from ADM muscle, abnormal
latency difference or amplitude drop was not detected
in 4 of 35 patients. The diagnosis of UNE in these four
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Table 3. Comparison of ulnar nerve conduction studies in mild UNE patients with normal and abnormal needle EMG findings.
Abnormal needle EMG
n = 12 mean ± SD (median)

Normal needle EMG
n = 11 mean ± SD (median)

P-value

5th digit-wrist segment SNAP amplitude (µV)

10.2 ± 2.3 (9.9)

11.4 ± 4.0(9.6)

0.689

5th digit-wrist segment SNAP velocity (m/s)

45.1 ± 5.2 (45.0)

43.9 ± 4.2 (44.0)

0.599

Forearm segment mixed nerve amplitude (µV)

10.6 ± 5.9 (9.8)

32.0 ± 22.7 (21.1)

0.004

Forearm segment mixed nerve velocity (m/s)

53.4 ± 6.3 (52.2)

53.5 ± 4.4 (53.0)

0.751

Upper arm segment mixed nerve amplitude (µV)

7.8 ± 9.7 (5.9)

11.9 ± 7.5(10.9)

0.182

Upper arm segment mixed nerve velocity (m/s)

56.2 ± 1.8 (56.0)

55.3 ± 5.3 (55.8)

0.571

CMAP amplitude-ADM (mV)

11.4 ± 2.6 (11.5)

13.6 ± 2.9 (13.2)

0.148

Elbow segment Velocity-ADM (m/s)

40.1 ± 6.8 (41.0)

52.2 ± 6.6 (53.0)

0.001

FEVD-ADM (m/s)

20.2 ± 10.1 (17.5)

10.6 ± 5.6 (12.0)

0.016

Amplitude drop-ADM (below elbow - above elbow) (%)

52.4 ± 39.3 (59.2)

5.8 ± 10.6 (3.4)

0.005

F-wave latency-ADM (ms)

29.3 ± 2.4 (28.8)

26.5 ± 2.2 (26.5)

0.016

CMAP amplitude-FDI (mV)

13.6 ± 4.9 (12.4)

17.3 ± 5.9 (17.1)

0.140

Elbow Velocity-FDI (m/s)

39.0 ± 6.7 (38.0)

47.6 ± 8.6 (45.0)

0.015

FEVD-FDI (m/s)

20.2 ± 6.4 (21.0)

14.7 ± 8.9 (15.0)

0.052

Amplitude drop-FDI (below elbow – above elbow) (%)

61.2 ± 37.2 (82.0)

8.4 ± 10.3 (5.0)

0.001

n: number of extremities, SD: standard deviation, CMAP: compound muscle action potential, SNAP: sensory nerve action potential,
FEVD: The velocity difference between the motor NCV of the forearm and elbow segments, ADM: abductor digiti minimi, FDI: first
dorsal interosseous. A P-value of less than 0.05 was considered significant (given in bold).

patients was detected in short-segment motor nerve
conduction study recorded from FDI muscle. Therefore,
we recommend performing ulnar motor nerve conduction
study from both ADM and FDI muscles in patients with
clinical suspicion. Although there was no significant
difference in the sensitivity of motor nerve conduction
studies recorded from ADM and FDI muscles in previous
studies, nerve conduction studies recorded from two
muscles rather than from one muscle would lead to more
patients diagnosed with UNE [6,12].
Similar to previous studies, paresthesia was the most
common symptom in the fourth and fifth fingers, and the
most common abnormality in neurological examination
was sensory abnormalities in these fingers [6,10,12,19].
Elbow or forearm pain was less frequent than fourth and
fifth finger paresthesia. The DASH questionnaire appears
to be a questionnaire that can assess UNE symptoms well.
A positive correlation between the DASH scores and the
neurophysiological classification of UNE was also found
in previous studies such as this study, ant this finding was
important in showing that the DASH questionnaire can
be used in UNE [10]. Short-segment ulnar motor nerve
conduction study at the elbow is considered the gold
standard for the diagnosis of UNE [3-6]. For this reason,
we planned to include patients with abnormalities in the
short-segment (5 × 2 cm) ulnar motor nerve conduction
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study. The reference values we found for latency differences
and amplitude drop in 2 cm segments were similar to
those of previous studies [4,13,19]. In controls, the most
prominent latency changes at the elbow were observed in
D2-E and E-P2 segments, similar to the findings of other
studies [3–5,13,19]. In our study, ulnar nerve entrapment
in the E-P2 segment was found in 29 of 35 UNE patients.
Retroepicondylar entrapment of the ulnar nerve is more
common than other sites in UNE [6,18]. In previous
studies, a lesion in humeroulnar aponeurotic arcade
(HUA) in UNE is seen in 15–20% of patients [3,6,18,20].
The entrapment site was HUA in 5 patients (14%) in our
study. Four of these five patients were in the severe UNE
group and all of these five patients had abnormal EMG
findings in at least one muscle. There are studies showing
that axon damage is higher in entrapment in HUA and
that demyelination is more prominent in entrapment in
retroepicondylar groove, and these studies support our
findings [6,18]. UNE can also be classified by lesion site,
axonal damage is more pronounced in HUA.
In UNE, it is known that hand muscles innervated
by ulnar nerve are more affected than proximal muscles
[6,12,21]. Similarly, in our study, ADM and FDI muscles
were more affected than FDP and FCU muscles. This
pattern of involvement can be explained by the topographic
distribution of the ulnar nerve fascicles [22]. Forearm
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muscles may be better protected than hand muscles. In a
study by Eliaspour et al., muscle involvement was much
higher than ours in UNE. In the study of Eliaspor, the
percentage of involvement of ADM, FDI, FCU, and FDP
muscles in UNE patients were 91.3%, 91.9%, 64.9%, and
56.8%, respectively [21]. This difference can be explained by
methodological reasons and patient characteristics. In this
study, the ulnar nerve CMAP or SNAP abnormalities were
much higher than in our study, and in contrast to our study,
needle EMG abnormality was one of the UNE diagnostic
criteria. In addition, we did not include the presence of
motor unit recruitment abnormality in neurogenic MUP
criteria. For these reasons, muscle involvement rates were
lower in our study. The percentage of muscle involvement
was similar to that of the study by Beekman [12]. The
symptom duration of the patients in our study ranged from
1 to 60 months. Therefore, in the case of one of the active
denervation or neurogenic changes, needle EMG would
be appropriate to be considered abnormal. All patients
with moderate and severe UNE had at least one muscle
abnormality innervated by ulnar nerve. In mild UNE,
needle EMG was normal in 11 of 23 patients. In mild UNE
patients with abnormal EMG findings, ulnar nerve motor
NCV across the elbow was significantly slower, amplitude
drop at the elbow and FEVD and ulnar F-wave latency
was significantly higher than in mild UNE patients with
normal needle EMG findings. These findings may indicate
that needle EMG abnormalities may be due not only to
axonal damage but also to the motor conduction block.
This may be due to loss of a small amount of motor axons
in the region where there is severe demyelination [23]. In
addition, amplitude of forearm ulnar mixed nerve action
potential was significantly lower in mild UNE patients
with abnormal EMG compared to those with normal
EMG. All these findings may suggest that electrodiagnostic
tests and clinical examinations should be performed more
frequently in these mild UNE patients.
There are many clinical classifications and
questionnaires related to UNE [7-9] but few

neurophysiological classifications in the literature (10,11).
There is an article on neurophysiological classification
using nerve conduction study and needle EMG findings
(11). In this article, this classification was described in
two cases. In our study, abnormal needle EMG findings
were present in more than half of mild UNE patients and
all moderate and severe UNE patients. In addition, as we
have just mentioned, needle EMG abnormalities can be
seen due to axonal damage or motor conduction block.
Therefore, a neurophysiological classification involving
needle EMG findings may not be useful. However, needle
EMG is useful in showing axonal degeneration in some
mild UNE patients or in differential diagnosis. UNE
patients with needle EMG abnormalities should be closely
monitored.
There were some limitations in our study. First, the
symptom duration of the patients was variable. In patients
with a symptom duration of 1 month, MUPs with chronic
neurogenic changes may develop later. Second, the number
of mild UNE patients with abnormal and normal needle
EMG findings was low. However, it should be noted that
patients with diabetes mellitus, carpal tunnel syndrome, or
polyneuropathy were excluded from the study.
We think that it is impractical to use needle EMG
findings in neurophysiological classification, as needle
EMG abnormalities can be seen in most UNE patients
and at each UNE stage. Abnormal needle EMG findings
indicative of axonal damage or motor conduction block
may be seen in mild UNE patients. Follow-up studies of
these mild UNE patients will provide information about
the prognosis of these patients.
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